Overview

Sildenafil in Acute Pulmonary Embolism

Status:
Completed

Trial end date:
2018-09-10

Target enrollment:

Participant gender:

Summary

To investigate if acute pulmonary vasodilation by sildenafil improves right ventricular function in patients with acute intermediate-high risk pulmonary embolism (PE).

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Aarhus

Treatments:

Sildenafil Citrate